Malignant Uterine Neoplasm — Trials

Malignant Uterine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,291 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 824
Recruiting: 456
Ph III recruiting: 55
Growth YoY: −3.6%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 25.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (333)

clinicaltrialsPublishedShowing 51–56 of 56 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06036121	A Study of ADRX-0706 in Select Advanced Solid Tumors	active not recruiting	Phase 1	144	Adcentrx TherapeuticsINDUSTRY	2	Aug 17, 2025	clinicaltrials
NCT05057013	A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours	active not recruiting	Phase 1 / Phase 2	81	Cancer Research UKOTHER	1	Aug 11, 2025	clinicaltrials
NCT04706962